tiprankstipranks
Avantor (DE:AVG)
NYSE:AVG
Germany Market

Avantor (AVG) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

AVG Analyst Ratings

Hold
9Ratings
Hold
0 Buy
7 Hold
2 Sell
Based on 9 analysts giving stock ratings to
Avantor
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AVG Stock 12 Month Forecast

Average Price Target

€7.00
▼(-0.05% Downside)
Based on 9 Wall Street analysts offering 12 month price targets for Avantor in the last 3 months. The average price target is €7.00 with a high forecast of €7.75 and a low forecast of €6.03. The average price target represents a -0.05% change from the last price of €7.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"€5","12":"€12","6.75":"€6.75","8.5":"€8.5","10.25":"€10.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7.74998883,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€7.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.99651769375,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€7.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.0277690900000005,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€6.03</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,6.75,8.5,10.25,12],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.732,7.733383756153846,7.734767512307693,7.736151268461539,7.737535024615385,7.7389187807692315,7.740302536923077,7.741686293076923,7.743070049230769,7.744453805384616,7.745837561538462,7.747221317692308,7.7486050738461545,{"y":7.74998883,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.732,7.6754244379807695,7.618848875961539,7.562273313942308,7.505697751923077,7.4491221899038464,7.392546627884616,7.335971065865385,7.279395503846154,7.222819941826923,7.166244379807693,7.109668817788462,7.053093255769231,{"y":6.99651769375,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.732,7.600905314615384,7.4698106292307695,7.338715943846154,7.207621258461539,7.076526573076923,6.945431887692308,6.8143372023076925,6.683242516923078,6.552147831538462,6.421053146153847,6.289958460769231,6.158863775384615,{"y":6.0277690900000005,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":11.1,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.2,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.1,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.4,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.55,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.9,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.5,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.95,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":7.45,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6.65,"date":1775001600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":6.612,"date":1777593600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":7.732,"date":1780272000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€7.75Average Price Target€7.00Lowest Price Target€6.03
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wolfe Research Analyst forecast on DE:AVG
Wolfe Research
Wolfe Research
€6.03
Sell
-13.89%
Downside
Assigned
06/01/26
Avantor assumed with Underperform from Peer Perform at Wolfe ResearchAvantor assumed with Underperform from Peer Perform at Wolfe Research
RBC Capital Analyst forecast on DE:AVG
RBC Capital
RBC Capital
€7.75
Hold
10.71%
Upside
Initiated
05/14/26
Avantor resumed with a Sector Perform at RBC CapitalAvantor resumed with a Sector Perform at RBC Capital
Citi
€9.47€7.75
Hold
10.71%
Upside
Reiterated
04/30/26
Avantor price target lowered to $9 from $11 at CitiAvantor price target lowered to $9 from $11 at Citi
Stifel Nicolaus Analyst forecast on DE:AVG
Stifel Nicolaus
Stifel Nicolaus
€8.61€6.89
Hold
-1.59%
Downside
Reiterated
04/30/26
Avantor price target lowered to $8 from $10 at StifelAvantor price target lowered to $8 from $10 at Stifel
Evercore ISI Analyst forecast on DE:AVG
Evercore ISI
Evercore ISI
€7.32€6.89
Hold
-1.59%
Downside
Reiterated
04/30/26
Avantor price target lowered to $8 from $8.50 at Evercore ISIAvantor price target lowered to $8 from $8.50 at Evercore ISI
Barclays Analyst forecast on DE:AVG
Barclays
Barclays
€6.03
Sell
-13.89%
Downside
Reiterated
04/30/26
Barclays Reaffirms Their Sell Rating on Avantor (AVTR)
J.P. Morgan Analyst forecast on DE:AVG
J.P. Morgan
J.P. Morgan
€6.89
Hold
-1.59%
Downside
Reiterated
04/30/26
Analysts Conflicted on These Healthcare Names: Irhythm Technologies (NASDAQ: IRTC), Alnylam Pharma (NASDAQ: ALNY) and Avantor (NYSE: AVTR)
TD Cowen
€8.61€7.75
Hold
10.71%
Upside
Reiterated
04/29/26
Avantor Kept at Hold as Analyst Trims Price Target to $9 Amid Execution and Market Recovery Risks
William Blair Analyst forecast on DE:AVG
William Blair
William Blair
Hold
Reiterated
04/29/26
Analysts Offer Insights on Healthcare Companies: Avantor (NYSE: AVTR) and AbbVie (NYSE: ABBV)
Wells Fargo
€13.78€12.06
Buy
72.22%
Upside
Reiterated
02/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Avantor (NYSE: AVTR) and Moderna (NASDAQ: MRNA)
Morgan Stanley Analyst forecast on DE:AVG
Morgan Stanley
Morgan Stanley
€10.33€8.61
Hold
23.02%
Upside
Reiterated
02/13/26
Morgan Stanley Sticks to Their Hold Rating for Avantor (AVTR)
Robert W. Baird
€12.92€9.47
Buy
35.32%
Upside
Reiterated
02/12/26
Avantor price target lowered to $11 from $15 at BairdAvantor price target lowered to $11 from $15 at Baird
Jefferies
€6.89
Sell
-1.59%
Downside
Reiterated
02/12/26
Avantor price target lowered to $8 from $9 at JefferiesAvantor price target lowered to $8 from $9 at Jefferies
Bank of America Securities Analyst forecast on DE:AVG
Bank of America Securities
Bank of America Securities
€11.19€9.47
Hold
35.32%
Upside
Reiterated
02/11/26
Avantor price target lowered to $11 from $13 at BofAAvantor price target lowered to $11 from $13 at BofA
Nephron Analyst forecast on DE:AVG
Unknown Analyst
Nephron
Not Ranked
Nephron
€6.89
Sell
-1.59%
Downside
Downgraded
12/11/25
Avantor downgraded to Sell from Hold at Nephron ResearchAvantor downgraded to Sell from Hold at Nephron Research
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Wolfe Research Analyst forecast on DE:AVG
Wolfe Research
Wolfe Research
€6.03
Sell
-13.89%
Downside
Assigned
06/01/26
Avantor assumed with Underperform from Peer Perform at Wolfe ResearchAvantor assumed with Underperform from Peer Perform at Wolfe Research
RBC Capital Analyst forecast on DE:AVG
RBC Capital
RBC Capital
€7.75
Hold
10.71%
Upside
Initiated
05/14/26
Avantor resumed with a Sector Perform at RBC CapitalAvantor resumed with a Sector Perform at RBC Capital
Citi
€9.47€7.75
Hold
10.71%
Upside
Reiterated
04/30/26
Avantor price target lowered to $9 from $11 at CitiAvantor price target lowered to $9 from $11 at Citi
Stifel Nicolaus Analyst forecast on DE:AVG
Stifel Nicolaus
Stifel Nicolaus
€8.61€6.89
Hold
-1.59%
Downside
Reiterated
04/30/26
Avantor price target lowered to $8 from $10 at StifelAvantor price target lowered to $8 from $10 at Stifel
Evercore ISI Analyst forecast on DE:AVG
Evercore ISI
Evercore ISI
€7.32€6.89
Hold
-1.59%
Downside
Reiterated
04/30/26
Avantor price target lowered to $8 from $8.50 at Evercore ISIAvantor price target lowered to $8 from $8.50 at Evercore ISI
Barclays Analyst forecast on DE:AVG
Barclays
Barclays
€6.03
Sell
-13.89%
Downside
Reiterated
04/30/26
Barclays Reaffirms Their Sell Rating on Avantor (AVTR)
J.P. Morgan Analyst forecast on DE:AVG
J.P. Morgan
J.P. Morgan
€6.89
Hold
-1.59%
Downside
Reiterated
04/30/26
Analysts Conflicted on These Healthcare Names: Irhythm Technologies (NASDAQ: IRTC), Alnylam Pharma (NASDAQ: ALNY) and Avantor (NYSE: AVTR)
TD Cowen
€8.61€7.75
Hold
10.71%
Upside
Reiterated
04/29/26
Avantor Kept at Hold as Analyst Trims Price Target to $9 Amid Execution and Market Recovery Risks
William Blair Analyst forecast on DE:AVG
William Blair
William Blair
Hold
Reiterated
04/29/26
Analysts Offer Insights on Healthcare Companies: Avantor (NYSE: AVTR) and AbbVie (NYSE: ABBV)
Wells Fargo
€13.78€12.06
Buy
72.22%
Upside
Reiterated
02/13/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Avantor (NYSE: AVTR) and Moderna (NASDAQ: MRNA)
Morgan Stanley Analyst forecast on DE:AVG
Morgan Stanley
Morgan Stanley
€10.33€8.61
Hold
23.02%
Upside
Reiterated
02/13/26
Morgan Stanley Sticks to Their Hold Rating for Avantor (AVTR)
Robert W. Baird
€12.92€9.47
Buy
35.32%
Upside
Reiterated
02/12/26
Avantor price target lowered to $11 from $15 at BairdAvantor price target lowered to $11 from $15 at Baird
Jefferies
€6.89
Sell
-1.59%
Downside
Reiterated
02/12/26
Avantor price target lowered to $8 from $9 at JefferiesAvantor price target lowered to $8 from $9 at Jefferies
Bank of America Securities Analyst forecast on DE:AVG
Bank of America Securities
Bank of America Securities
€11.19€9.47
Hold
35.32%
Upside
Reiterated
02/11/26
Avantor price target lowered to $11 from $13 at BofAAvantor price target lowered to $11 from $13 at BofA
Nephron Analyst forecast on DE:AVG
Unknown Analyst
Nephron
Not Ranked
Nephron
€6.89
Sell
-1.59%
Downside
Downgraded
12/11/25
Avantor downgraded to Sell from Hold at Nephron ResearchAvantor downgraded to Sell from Hold at Nephron Research
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Avantor

3 Months
Success Rate
9/25 ratings generated profit
36%
Average Return
-5.96%
Copying Catherine Ramsey Schulte's trades and holding each position for 3 Months would result in 36.00% of your transactions generating a profit, with an average return of -5.96% per trade.
1 Year
Luke SergottBarclays
Success Rate
9/32 ratings generated profit
28%
Average Return
-15.78%
Copying Luke Sergott's trades and holding each position for 1 Year would result in 28.13% of your transactions generating a profit, with an average return of -15.78% per trade.
2 Years
Success Rate
3/17 ratings generated profit
18%
Average Return
-17.46%
Copying Brandon Couillard's trades and holding each position for 2 Years would result in 17.65% of your transactions generating a profit, with an average return of -17.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AVG Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
1
1
1
0
0
Buy
2
1
1
0
0
Hold
13
12
17
9
9
Sell
3
2
4
3
3
Strong Sell
0
0
0
0
0
total
19
16
23
12
12
In the current month, AVG has received 0 Buy Ratings, 9 Hold Ratings, and 3 Sell Ratings. AVG average Analyst price target in the past 3 months is 7.00.
Each month's total comprises the sum of three months' worth of ratings.

AVG Financial Forecast

AVG Earnings Forecast

Next quarter’s earnings estimate for AVG is €0.16 with a range of €0.15 to €0.17. The previous quarter’s EPS was €0.15. AVG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AVG has Performed in-line its overall industry.
Next quarter’s earnings estimate for AVG is €0.16 with a range of €0.15 to €0.17. The previous quarter’s EPS was €0.15. AVG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AVG has Performed in-line its overall industry.

AVG Sales Forecast

Next quarter’s sales forecast for AVG is €1.39B with a range of €1.37B to €1.42B. The previous quarter’s sales results were €1.36B. AVG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AVG has Performed in-line its overall industry.
Next quarter’s sales forecast for AVG is €1.39B with a range of €1.37B to €1.42B. The previous quarter’s sales results were €1.36B. AVG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AVG has Performed in-line its overall industry.

AVG Stock Forecast FAQ

What is DE:AVG’s average 12-month price target, according to analysts?
Based on analyst ratings, Avantor’s 12-month average price target is 7.00.
    What is DE:AVG’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for DE:AVG, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Avantor a Buy, Sell or Hold?
        Avantor has a consensus rating of Hold, which is based on 0 buy ratings, 7 hold ratings and 2 sell ratings.
          What is Avantor’s share price target?
          The average share price target for Avantor is 7.00. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €7.75 ,and the lowest forecast is €6.03. The average share price target represents -0.05% Decrease from the current price of €7.
            What do analysts say about Avantor?
            Avantor’s analyst rating consensus is a Hold. This is based on the ratings of 9 Wall Streets Analysts.
              How can I buy shares of Avantor?
              To buy shares of DE:AVG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.